Recent publications

Publications can be found through the individual profile pages of the division's staff members.

View the complete overview of the publications in PubMed.

Most recent publications

2025

Callenbach, M. H. E. (2025). Fertile Grounds for Outcome-based Managed Entry Agreements? Potential suitability and desirability for highly priced novel therapies. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2704
Dong, B., Lu, Z., Yang, T., Wang, J., Zhang, Y., Tuo, X., Wang, J., Lin, S., Cai, H., Cheng, H., Cao, X., Huang, X., Zheng, Z., Miao, C., Wang, Y., Xue, H., Xu, S., Liu, X., Zou, H., & Sun, P. (2025). Development, validation, and clinical application of a machine learning model for risk stratification and management of cervical cancer screening based on full-genotyping hrHPV test (SMART-HPV): a modelling study. The Lancet Regional Health - Western Pacific, 55, Article 101480. https://doi.org/10.1016/j.lanwpc.2025.101480
Lasys, T., Santa-Ana-Tellez, Y., Siiskonen, S. J., Groenwold, R. H. H., & Gardarsdottir, H. (2025). Impact of Pharmacovigilance Interventions Targeting Fluoroquinolones on Antibiotic Use in the Netherlands and the United Kingdom. Pharmacoepidemiology and Drug Safety, 34(2), Article e70081. https://doi.org/10.1002/pds.70081
Davies, L. E. M., van den Ham, H. A., Schellekens, A. F. A., Philbert, D., & Bouvy, M. L. (2025). Patient satisfaction with prescription opioid education in primary care. Patient Education and Counseling, 131, Article 108572. https://doi.org/10.1016/j.pec.2024.108572
Trials@Home Consortium (2025). The impact of operational trial approaches on representativeness: Comparison of decentralized clinical trial participants, conventional trial participants, and patients in daily practice. Drug Discovery Today, 30(2), 1-11. Article 104304. https://doi.org/10.1016/j.drudis.2025.104304
Van Gelder, T. G., Vergoossen, D., Zonnenberg, I. A., Lalmohamed, A., Koole-Oostveen, M. I., van Reij, E. M. L., van Loon, A., & Egberts, T. C. G. (2025). Physical compatibility of insulin aspart, lidocaine, alprostadil and vancomycin with individualised two-in-one parenteral nutrition used in the neonatal intensive care unit. European Journal of Hospital Pharmacy. Advance online publication. https://doi.org/10.1136/ejhpharm-2024-004300
Essink, S. C. M., Zomerdijk, I. M., Goedecke, T., Straus, S. M. J. M., Gardarsdottir, H., & De Bruin, M. L. (2025). Duration of Time Intervals for Risk Minimization Measure Effectiveness Studies. Clinical Pharmacology and Therapeutics. Advance online publication. https://doi.org/10.1002/cpt.3569
de Jong, A. J., Gardarsdottir, H., Santa-Ana-Tellez, Y., de Boer, A., & Zuidgeest, M. G. (2025). Experiences with low-intervention clinical trials-the new category under the European Union Clinical Trials Regulation. Clinical Trials. Advance online publication. https://doi.org/10.1177/17407745241309293
Schultze, A., Martin, I., Messina, D., Bots, S., Belitser, S., Carreras-Martínez, J. J., Correcher-Martinez, E., Urchueguía-Fornes, A., Martín-Pérez, M., García-Poza, P., Villalobos, F., Pallejà-Millán, M., Bissacco, C. A., Segundo, E., Souverein, P., Riefolo, F., Durán, C. E., Gini, R., Sturkenboom, M., ... Douglas, I. (2025). Corrigendum to “A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases” [Vaccine 42 (12) (2024) 3039–3048, (S0264410X2400330X), (10.1016/j.vaccine.2024.03.043)]. Vaccine, 44, 126438. Article 126438. https://doi.org/10.1016/j.vaccine.2024.126438
Mertens, J. F., Hessel, M. H. M., Kempen, T. G. H., Böhringer, S., Norbart, A. F., Walinga, C. W., & van Gelder, T. (2025). Evaluation of an interprofessional education program involving medical and pharmacy students: a mixed-method study. BMC Medical Education, 25(1), Article 48. https://doi.org/10.1186/s12909-024-06574-w
Kruijtbosch, M., Floor-Schreudering, A., van Leeuwen, E., & Bouvy, M. L. (2025). Fostering moral reflectivity in community pharmacists through moral case deliberation using the dilemma method. International Journal of Clinical Pharmacy. Advance online publication. https://doi.org/10.1007/s11096-024-01854-3
Schouten, W. M., Van Bocxlaer, K., Rosing, H., Huitema, A. D. R., Beijnen, J. H., Kratz, J. M., Mowbray, C. E., & Dorlo, T. P. C. (2025). Development and validation of ultra-performance liquid chromatography tandem mass spectrometry methods for the quantitative analysis of the antiparasitic drug DNDI-6148 in human plasma and various mouse biomatrices. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1250, 1-11. Article 124377. https://doi.org/10.1016/j.jchromb.2024.124377
Hogervorst, M. A., Soman, K. V., Gardarsdottir, H., Goettsch, W. G., & Bloem, L. T. (2025). Analytical Methods for Comparing Uncontrolled Trials with External Controls from Real-World Data: a Systematic Literature Review and Comparison to European Regulatory and Health Technology Assessment Practice. Value in Health, 28(1), 161-174. https://doi.org/10.1016/j.jval.2024.08.002
Bots, S. H., Belitser, S., Groenwold, R. H. H., Durán, C. E., Riera-Arnau, J., Schultze, A., Messina, D., Segundo, E., Douglas, I., Carreras, J. J., Garcia-Poza, P., Gini, R., Huerta, C., Martín-Pérez, M., Martin, I., Paoletti, O., Bissacco, C. A., Correcher-Martínez, E., Souverein, P., ... Klungel, O. H. (2025). Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example. American Journal of Epidemiology, 194(1), Article kwae172. https://doi.org/10.1093/aje/kwae172
Lips, N., Singh, A., Weir, D., & Karapinar-Carkit, F. (2025). Comparing the performance of multiple trigger tools in identifying medication-related hospital readmissions. Journal of the American Geriatrics Society, 73(1), 162-171. https://doi.org/10.1111/jgs.19216
Bots, S. H., Brown, J., Wong, A. Y. S., Martin, I., Douglas, I., Klungel, O. H., & Schultze, A. (2025). Core Concepts: Self-Controlled Designs in Pharmacoepidemiology. Pharmacoepidemiology and Drug Safety, 34(1), Article e70071. https://doi.org/10.1002/pds.70071
Dutch CDSS‐efficiency study group, Graafsma, J., van de Garde, E. M. W., Derijks, H. J., Hoge, R. H. L., Klopotowska, J. E., Karapinar-Carkit, F., & van den Bemt, P. M. L. A. (2025). Efficiency of computerized clinical decision support systems involving anticoagulants: A flashmob study in Dutch hospital pharmacies. British Journal of Clinical Pharmacology, 91(1), 157-165. https://doi.org/10.1111/bcp.16236
Costa, E., Ware, R. E., Tshilolo, L., Makani, J., Leufkens, H. G. M., & Luzzatto, L. (2025). Globalization in clinical drug development for sickle cell disease. American Journal of Hematology, 100(1), 4-9. https://doi.org/10.1002/ajh.27525
Jansen, M. S., Dekkers, O. M., Cessie, S. L., Hooft, L., Gardarsdottir, H., de Boer, A., & Groenwold, R. H. H. (2025). Multiple Perspectives on the Need for Real‐World Evidence to Inform Regulatory and Health Technology Assessment Decision‐Making: Scoping Review and Stakeholder Interviews. Pharmacoepidemiology and Drug Safety, 34(1), 1-16. Article e70074. https://doi.org/10.1002/pds.70074
Scholte, M., Grimm, S. E., Pauly, B., Verbeeck, F., Pasmooij, A. M. G., Bouma, B., van Duijn-Wiersma, J., Guney, E., Kesselheim, A. S., Schmidt, H. H. H. W., & Joore, M. A. (2025). Revising EU pharmaceutical legislation: will it foster drug repurposing? Drug Discovery Today, 30(1), Article 104286. https://doi.org/10.1016/j.drudis.2024.104286
Bloem, L. T., Leufkens, H. G. M., Berends, S. E., Vreman, R. A., Hollak, C. E. M., van Weely, S., de Lannoy, L. M., Bertens, P. J. A., & Pasmooij, A. M. G. (2025). Stimulating development of innovative medicines in the European Union: does a new definition for unmet medical need add value? Drug Discovery Today, 30(1), Article 104251. https://doi.org/10.1016/j.drudis.2024.104251
Callenbach, M. H. E., Vreman, R. A., Leopold, C., Mantel-Teeuwisse, A. K., & Goettsch, W. G. (2025). Managed Entry Agreements for High-Cost, One-Off Potentially Curative Therapies: A Framework and Calculation Tool to Determine Their Suitability. PharmacoEconomics, 43, 53-66. https://doi.org/10.1007/s40273-024-01433-4
on behalf of The N-of-1 Task Force of the International Rare Diseases Research Consortium (IRDiRC), Jonker, A. H., Tataru, E. A., Graessner, H., Dimmock, D., Jaffe, A., Baynam, G., Davies, J., Mitkus, S., Iliach, O., Horgan, R., Augustine, E. F., Bateman-House, A., Pasmooij, A. M. G., Yu, T., Synofzik, M., Douville, J., Lapteva, L., Brooks, P. J., ... Aartsma-Rus, A. (2025). The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap. Nature Reviews Drug Discovery, 24(1), 40-56. Article e10486. https://doi.org/10.1038/s41573-024-01059-3

2024

Saylor, D., Rijke, N., McDonell, J., Laurson-Doube, J., Avasarala, J., Baldin, E., Banerjee, T. K., Bogdanovic, I., Bove, R., Chawla, D. K., Costello, K., Del Giovane, C., Abkari, N. E., Filippini, G., Foschi, M., Gonzalez-Lorenzo, M., Helme, A., Jacobs, D., Kalincik, T., ... Piggott, T. (2024). Recommendations for essential medicines for multiple sclerosis in low-resource settings. Multiple Sclerosis Journal. Advance online publication. https://doi.org/10.1177/13524585241308134
Schmidt, M., Vernooij, R., van Nuland, M., Smeijsters, E., Devriese, L., Mohammad, N. H., Hermens, T., Stammers, J., Swart, C., Egberts, T., Haitjema, S., & Lammers, L. (2024). Impaired liver function: effect on paclitaxel toxicity, dose modifications and overall survival. BMC Cancer, 24(1), Article 1553. https://doi.org/10.1186/s12885-024-13330-2
Wolthuis, D. F. G. J., Nijenhuis, M., Soree, B., de Boer-Veger, N. J., Buunk, A. M., Guchelaar, H. J., Risselada, A., Rongen, G. A. P. J. M., van Schaik, R. H. N., Swen, J. J., Touw, D. J., van Westrhenen, R., Deneer, V. H. M., & Houwink, E. J. F. (2024). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between SLCO1B1 and statins and CYP2C9 and sulfonylureas. European Journal of Human Genetics. Advance online publication. https://doi.org/10.1038/s41431-024-01769-7
Ensing, H. T., Kurt, N., Janssen, R. A., Koster, E. S., & Heerdink, E. R. (2024). Pharmacist-led new medicine service: a real-world cohort study in the Netherlands on drug-related problems, satisfaction, and self-efficacy in cardiovascular patients transitioning to primary care. International Journal of Clinical Pharmacy, Article e80633. Advance online publication. https://doi.org/10.1007/s11096-024-01829-4
Taams, A. C., Herberts, C. A., Egberts, A. C. G., Zafiropoulos, N., Pignatti, F., & Bloem, L. T. (2024). Uncertainties about the benefit-risk balance of oncology medicines assessed by the European Medicines Agency. ESMO Open, 9(12), Article 103991. Advance online publication. https://doi.org/10.1016/j.esmoop.2024.103991
Hunt, N. B. (2024). Multi-Database Methodologies to Enhance Real-World Evidence Generation. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2547
Kaymakci, B., Philbert, D., Hazen, A. C. M., Heringa, M., Kwint, H. F., Zwart, D. L. M., van Dijk, L., Kälvemark Sporrong, S., & Kempen, T. G. H. (2024). Pharmacists’ perspectives on potential pharmacist prescribing: a nationwide survey in the Netherlands. International Journal of Clinical Pharmacy. Advance online publication. https://doi.org/10.1007/s11096-024-01842-7
Leung, M. W. Y., Bazelier, M. T., Uitdehaag, B. M. J., De Jong, H. J. I., Klungel, O. H., & van de Garde, E. M. W. (2024). Antibiotic Utilization Among People With Multiple Sclerosis in the Netherlands, 2018–2020. Pharmacoepidemiology and Drug Safety, 33(12), Article e70070. https://doi.org/10.1002/pds.70070
Mohmaed Ali, M. I., Nijstad, A. L., Boosman, R. J., Crombag, M. R. B. S., Barnett, S., Veal, G. J., Lalmohamed, A., van Erp, N. P., Steeghs, N., Zwaan, C. M., Beijnen, J. H., Siebinga, H., & Huitema, A. D. R. (2024). A Population Pharmacokinetic Study to Evaluate Doxorubicin Exposure Across All Age Groups. Clinical Pharmacokinetics, 63(12), 1711-1722. https://doi.org/10.1007/s40262-024-01445-5
Falke, C., Karapinar, F., Bouvy, M., Emmelot, M., Belitser, S., Boland, B., O'Mahony, D., Murphy, K. D., Haller, M., Salari, P., Schwenkglenks, M., Rodondi, N., Egberts, T., & Knol, W. (2024). Correction: The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy. European Geriatric Medicine, 15, 1725-1730. https://doi.org/10.1007/s41999-024-01072-0
Iversen, D. B., Dunvald, A.-C. D., Ernst, M. T., Abtahi, S., Souverein, P., Klungel, O., Jeppesen, G. B., Nielsen, F., Brøsen, K., Hammer, H. S., Pötz, O., Damkier, P., Järvinen, E., Pottegård, A., & Stage, T. B. (2024). Dicloxacillin is an inducer of intestinal P-glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users. British Journal of Clinical Pharmacology, 90(12), 3252-3262. https://doi.org/10.1111/bcp.16190
Zinken, J. F., Pasmooij, A. M. G., Ederveen, A. G. H., Hoekman, J., & Bloem, L. T. (2024). Environmental risk assessment in the EU regulation of medicines for human use: an analysis of stakeholder perspectives on its current and future role. Drug Discovery Today, 29(12), Article 104213. https://doi.org/10.1016/j.drudis.2024.104213
van Vliet, E., Lipovec, N. Č., van der Goot, M., Abtahi, S., Ribeiro-Vaz, I., Poplavska, E., Dermiki-Gkana, F., Oikonomou, C., Deligianni, E., Kontogiorgis, C., Silva, A. M., Ferreira, P. B. S., Kos, M., Almarsdóttir, A. B., Jacobsen, R., Buhl, C., de Bruijn, A., Hegger, I., & Alves, T. L. (2024). Impact of Regulatory Risk Communication on Thrombosis With Thrombocytopenia Syndrome for COVID-19 Adenovirus Vector Vaccines on European Healthcare Professionals. Pharmacoepidemiology and Drug Safety, 33(12), Article e70057. https://doi.org/10.1002/pds.70057
Coppes, T., Philbert, D., Van Riet, M., van Gelder, T., Bouvy, M., & Koster, E. (2024). Medication management during risk of dehydration: A qualitative study among elderly patients with impaired renal function and informal caregivers. European Journal of General Practice, 30(1), Article 2413097. https://doi.org/10.1080/13814788.2024.2413097
Luijken, K., Morzywołek, P., van Amsterdam, W., Cinà, G., Hoogland, J., Keogh, R., Krijthe, J. H., Magliacane, S., van Ommen, T., Peek, N., Putter, H., van Smeden, M., Sperrin, M., Wang, J., Weir, D. L., Didelez, V., & van Geloven, N. (2024). Risk-Based Decision Making: Estimands for Sequential Prediction Under Interventions. Biometrical Journal, 66(8), Article e70011. https://doi.org/10.1002/bimj.70011
van Loon, E., Heringa, M., Floor-Schreudering, A., de Smet, P., & Bouvy, M. (2024). Relevance of therapeutic prescription modifications in Dutch community pharmacies. The International Journal of Pharmacy Practice, Article riae060. Advance online publication. https://doi.org/10.1093/ijpp/riae060
van Dam, C. J., Kramers, C., Schellekens, A., Bouvy, M., van Dorp, E., Kowal, M. A., Olofsen, E., Dahan, A., Niesters, M., & van Velzen, M. (2024). Cannabis combined with oxycodone for pain relief in fibromyalgia pain: a randomized clinical self-titration trial with focus on adverse events. Frontiers in Pain Research, 5, 1-10. Article 1497111. https://doi.org/10.3389/fpain.2024.1497111
Tamblyn, R., Habib, B., Buckeridge, D. L., Weir, D. L., Frolova, E., Alattar, R., Rogozinsky, J., Beauchamp, C., Pupo, R., Bartlett, S. J., & McDonald, E. (2024). Evaluating the effectiveness of the Smart About Meds (SAM) mobile application among patients discharged from hospital: protocol of a randomised controlled trial. BMJ Open, 14(11), Article e084492. https://doi.org/10.1136/bmjopen-2024-084492
Møllebæk, M., Gardarsdottir, H., Bikou, A. G., Kodrič, A., Silva, A. M., Andersen, A., Kontogiorgis, C., Poplavska, E., Ahmadizar, F., Dermiki-Gkana, F., Rutkovska, I., Vaz, I. R., Kos, M., Barão, P., Grupstra, R., Alves, T. L., & Almarsdóttir, A. B. (2024). Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case Study. Drug Safety. Advance online publication. https://doi.org/10.1007/s40264-024-01487-5
Jiu, L., Wang, J., Versteeg, J.-W., Zhang, Y., Liu, L., Somolinos-Simón, F. J., Tapia-Galisteo, J., García-Sáez, G., Hogervorst, M. A., Li, X., Mantel-Teeuwisse, A. K., & Goettsch, W. G. (2024). Roadmap to Innovation of HTA Methods (IHTAM): insights from three case studies of quantitative methods. International Journal of Technology Assessment in Health Care, 40(1), 1-10. Article e49. https://doi.org/10.1017/S0266462324000564
Elvidge, J., Crabb, N., Delnoij, D., Knies, S., Lundin, D., Houÿez, F., Röning, J., Wang, J., Jiu, L., Bennett, A., Zhang, Y., & Dawoud, D. (2024). Implementing a sandbox approach in health technology assessment: Benefits and recommendations. International Journal of Technology Assessment in Health Care, 40(1), Article e44. https://doi.org/10.1017/S0266462324000412
Troost, I., van den Bosch, L. J., Nederlof, N., Nazar, S., Wijers, M., Bakker, A., & Pieters, T. (2024). Student assistants as mentor-participants: A case study of distributing leadership in academic co-design education. Frontiers in Education, 9, 1-7. Article 1389065. https://doi.org/10.3389/feduc.2024.1389065
Stoelinga, J., Bloem, L. T., Russo, M., Kesselheim, A. S., & Feldman, W. B. (2024). Comparing supplemental indications for cancer drugs approved in the US and EU. European Journal of Cancer, 212, Article 114330. https://doi.org/10.1016/j.ejca.2024.114330
Beunk, L., Nijenhuis, M., Soree, B., de Boer-Veger, N. J., Buunk, A.-M., Guchelaar, H.-J., Houwink, E. J. F., Risselada, A., Rongen, G. A. P. J. M., van Schaik, R. H. N., Swen, J. J., Touw, D., Deneer, V. H. M., & van Westrhenen, R. (2024). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP2C19 and non-SSRI/non-TCA antidepressants. European Journal of Human Genetics, 32(11), 1371-1377. https://doi.org/10.1038/s41431-024-01648-1
Brinkhuis, F., Ruof, J., Ham, H. V. D., Gianfrate, F., Strammiello, V., Berntgen, M., Pavlovic, M., Mol, P. G. M., Wasem, J., Dyck, W. V., Cardone, A., Dierks, C., Schiel, A., Solà-Morales, O., Goettsch, W., & Julian, E. (2024). Evaluating progress towards implementation of the European HTA Regulation: Insights generated from the European Access Academy's multi-stakeholder survey. Health Policy and Technology, 13(5), Article 100930. https://doi.org/10.1016/j.hlpt.2024.100930
van Hattem, C. C., de Jong, A. J., de Groot, J. S., Hoekman, J., Broekman, K. E., Sonke, G. S., van Hennik, P. B., & Bloem, L. T. (2024). Factors affecting the feasibility of post-authorisation RCTs for conditionally authorised anticancer medicines: a multistakeholder perspective from a qualitative focus group study. BMJ Open, 14(11), Article e084483. https://doi.org/10.1136/bmjopen-2024-084483
Jadoenathmisier, K. D., Stoyanova-Beninska, V., Soons, I. M., Leufkens, H. G., Bloem, L. T., & Pasmooij, A. M. (2024). Feasibility of disease terminology systems for mapping orphan conditions and therapeutic indications of designated orphan medicines in the European Union. European Journal of Pharmaceutical Sciences, 202, Article 106871. https://doi.org/10.1016/j.ejps.2024.106871
Jansen-Groot Koerkamp, E. A. W., Weesie, Y. M., Heringa, M., Hek, K., Blom, J. W., Numans, M. E., van Dijk, L., & Bouvy, M. L. (2024). General practitioners' and community pharmacists' beliefs and practices on opioids for non-malignant pain. European Journal of Pain (United Kingdom), 28(10), 1719-1731. https://doi.org/10.1002/ejp.2304
Grupstra, R. J., Goedecke, T., & Gardarsdottir, H. (2024). Limitations Reported in Evaluating Effectiveness of Risk Minimization Measures in the EU during 2018-2021: A Qualitative Analysis of Industry-Sponsored Post-Authorization Safety Studies. Clinical Pharmacology & Therapeutics, 116(5), 1252-1258. https://doi.org/10.1002/cpt.3369
Avşar, T. S., Elvidge, J., Hawksworth, C., Kenny, J., Németh, B., Callenbach, M., Ringkvist, J., & Dawoud, D. (2024). Linking Reimbursement to Patient Benefits for Advanced Therapy Medicinal Products and Other High-Cost Innovations: Policy Recommendations for Outcomes-Based Agreements in Europe. Value in Health, 27(11), 1497-1506. https://doi.org/10.1016/j.jval.2024.07.007
de Jong, A. J., Zuidgeest, M. G. P., Santa-Ana-Tellez, Y., de Boer, A., Gardarsdottir, H., & Trials@Home Consortium (2024). Regulatory readiness to facilitate the appropriate use of innovation in clinical trials: The case of decentralized clinical trial approaches. Drug Discovery Today, 29(11), Article 104180. https://doi.org/10.1016/j.drudis.2024.104180
Canto, E. D., Uijl, A., Onland-Moret, N. C., Bots, S. H., Hofstra, L., Tulevski, I., Asselbergs, F. W., van der Harst, P., Somsen, G. A., & den Ruijter, H. M. (2024). Simplification of a registry-based algorithm for ejection fraction prediction in heart failure patients: Applicability in cardiology centres of the Netherlands. PLoS One, 19(11), Article e0310023. https://doi.org/10.1371/journal.pone.0310023
van Hulten, V., Souverein, P. C., Starup-Linde, J., Viggers, R., Klungel, O. H., Vestergaard, P., Brouwers, M. C. J. G., van den Bergh, J. P., & Driessen, J. H. M. (2024). The association of type 2 diabetes-related characteristics with fracture risk at different sites. Diabetes, Obesity and Metabolism, 26(11), 4887-4896. https://doi.org/10.1111/dom.15884
Pieters, T. (2024). Al ruime eeuw vinger aan de pols bij opioïdgebruik. Pharmaceutisch Weekblad, 159(43), 16-19. https://www.pw.nl/achtergrond/2024/al-ruime-eeuw-vinger-aan-de-pols-bij-opioidgebruik
van de Plas, A., Tanis, W. J., Deneer, V. H. M., Olsder, G., van der Lee, M. J., Hunfeld, N. G. M., Duyvendak, M., Karapinar-Çarkit, F., Rennenberg, R., & van den Bemt, P. M. L. A. (2024). RISICOGESTUURDE BENADERING OVERTROEFT DE DUBBELCHECK. Pharmaceutisch Weekblad, 159(42), 19-21. https://www.pw.nl/achtergrond/2024/risicogestuurde-benadering-overtroeft-de-dubbelcheck
Lentzas, A., Venekamp, N., Beijnen, J. H., & van Tellingen, O. (2024). Development and validation of an LC-MS/MS method for simultaneous quantification of eight drugs in plasma and brain: Application in a pharmacokinetic study in mice. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1247, Article 124308. https://doi.org/10.1016/j.jchromb.2024.124308
Bognàr, T., Garcia-Rosa, M., Lalmohamed, A., Güngör, T., Hauri-Hohl, M. M., Prockop, S. E., Oram, L. M., Pai, S.-Y., Brooks, J., Savic, R. M., Dvorak, C. C., Long-Boyle, J. R., Krajinovic, M., Bittencourt, H., Teyssier, A.-C., Theoret, Y., Martinez, C., Egberts, T. C. G., Morales, E., ... Bartelink, I. H. (2024). Association of Busulfan Exposure and Outcomes after HCT for Patients with an Inborn Error of Immunity. Blood advances, 8(19), 5137-5145. https://doi.org/10.1182/bloodadvances.2024013275
de Jong, A. J. (2024). Bringing clinical trials home: European regulatory perspectives on decentralized clinical trial approaches. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2431
Verschueren, M. V., Abedian Kalkhoran, H., Deenen, M., van den Borne, B. E. E. M., Zwaveling, J., Visser, L. E., Bloem, L. T., Peters, B. J. M., & van de Garde, E. M. W. (2024). Development and Portability of a Text Mining Algorithm for Capturing Disease Progression in Electronic Health Records of Patients With Stage IV Non-Small Cell Lung Cancer. JCO clinical cancer informatics, 8, Article e2400053. https://doi.org/10.1200/CCI.24.00053
Ogar, C. K., Gilbert, H. N., Bloem, L. T., Leopold, C., Bassi, P. U., Katagum, Y. M., Osakwe, A. I., Opadeyi, A. O., Oreagba, I., Mbo, D. N. D., Mantel-Teeuwisse, A. K., & De Bruin, M. L. (2024). Patient-reported outcomes of adverse events after COVID-19 vaccination in Nigeria: A mixed methods study. Vaccine, 42(23), Article 126196. https://doi.org/10.1016/j.vaccine.2024.126196
Van De Burgt, B. W. M., Wasylewicz, A. T. M., Dullemond, B., Jessurun, N. T., Grouls, R. J. E., Bouwman, R. A., Korsten, E. H. M., & Egberts, T. C. G. (2024). Development of a text mining algorithm for identifying adverse drug reactions in electronic health records. JAMIA Open, 7(3), Article ooae070. https://doi.org/10.1093/jamiaopen/ooae070
Smale, E. M., Ottenbros, A. B., van den Bemt, B. J. F., Heerdink, E. R., Verploegen, J., van Zelm, R., Egberts, T. C. G., & Bekker, C. L. (2024). Environmental Outcomes of Reducing Medication Waste by Redispensing Unused Oral Anticancer Drugs. JAMA network open, 7(10), Article e2438677. https://doi.org/10.1001/jamanetworkopen.2024.38677
Cam, H., Franzon, K., Sporrong, S. K., Kempen, T. G. H., Bernsten, C., Nielsen, E. I., Gustavsson, L., Moosavi, E., Lindmark, S., Ehlin, U., Sjölander, M., Lindner, K. J., & Gillespie, U. (2024). 'You're Just Thinking About Going Home': Exploring Person-Centred Medication Communication With Older Patients at Hospital Discharge. Health expectations : an international journal of public participation in health care and health policy, 27(5), Article e70065. https://doi.org/10.1111/hex.70065
Bognàr, T., Bartelink, I. H. I., van der Elst, K. C. M., Kingma, J. S., Smeijsters, E. H., Lindemans, C. A. C., Egberts, A. C. G. T., Kuball, J. H. E., de Witte, M. A., De Vries Schultink, A. H. M., & Lalmohamed, A. (2024). Busulfan exposure target attainment in adults undergoing allogeneic hematopoietic cell transplantation: a single day versus a multiple day therapeutic drug monitoring regimen. Transplantation and Cellular Therapy, 30(10), 1007.e1-1007.e10. https://doi.org/10.1016/j.jtct.2024.07.015
van Loon, W. E., Lambert, M., Heringa, M., Bouvy, M. L., & Taxis, K. (2024). Community pharmacists' attitudes towards checking prescriptions: a cross-sectional survey. The International Journal of Pharmacy Practice, 32(5), 363-368. Article riae030. https://doi.org/10.1093/ijpp/riae030
Opalska, A., Gardarsdottir, H., Kwa, M., Wójkowska‑Mach, J., Sabate, M., Ballarin, M. E., de Groot, M., & Leufkens, H. (2024). Correction to: Use of antibiotics in the early COVID-19 pandemic in Poland, the Netherlands and Spain, from erraticism to (more) logic (European Journal of Clinical Pharmacology, (2024), 80, 10, (1581-1589), 10.1007/s00228-024-03726-1). European Journal of Clinical Pharmacology, 80(10), 1591. https://doi.org/10.1007/s00228-024-03742-1
DECISION Investigators and Committees, van Veldhuisen, D. J., Rienstra, M., Mosterd, A., Alings, A. M., van Asselt, A. D. J., Bouvy, M. L., Tijssen, J. G. P., Schaap, J., van der Wall, E. E., Voors, A. A., Boorsma, E. M., Lok, D. J. A., Crijns, H. J. G. M., Schut, A., Vijver, M. A. T., Voordes, G. H. D., de Vos, A. H., Maas-Soer, E. L., ... van der Meer, P. (2024). Efficacy and safety of low-dose digoxin in patients with heart failure. Rationale and design of the DECISION trial. European Journal of Heart Failure, 26(10), 2223-2230. https://doi.org/10.1002/ejhf.3428
Meijvis, V. A. M., Heringa, M., Kwint, H.-F., de Wit, N. J., & Bouvy, M. L. (2024). Factors influencing the implementation of the CombiConsultation in Dutch clinical practice: a mixed-methods study. International Journal of Pharmacy Practice, 32(5), 347-354. https://doi.org/10.1093/ijpp/riae032
Pichler, F. B., Boysen, M., Mittmann, N., Gilardino, R., Bruce, A., Bond, K., Vreman, R. A., Largeron, N., Banhazi, J., Ollendorf, D. A., Jain, M., Upadhyaya, S., & Goettsch, W. G. (2024). Lifecycle HTA: Promising applications and a framework for implementation. International Journal of Technology Assessment in Health Care, 40(1), Article e50. https://doi.org/10.1017/S0266462324000187
Mertens, J. F., Kempen, T. G. H., Koster, E. S., Deneer, V. H. M., Bouvy, M. L., & van Gelder, T. (2024). Pharmacists and pharmacy students' perceptions on how a new teaching model supports their clinical decision-making. Currents in Pharmacy Teaching and Learning, 16(10), Article 102136. https://doi.org/10.1016/j.cptl.2024.102136
Versteeg, J.-W., Vreman, R., Mantel-Teeuwisse, A., & Goettsch, W. (2024). Uncertainty In Long-term Relative Effectiveness Of Medicines In Health Technology Assessment: Comparing Assessments Of Medicines For Spinal Muscular Atrophy, Cystic Fibrosis, And Hypercholesterolemia. Value in Health, 27(10), 1358-1366. https://doi.org/10.1016/j.jval.2024.05.023
Meije, R., Selvanayagam, T., Philbert, D., Bouvy, M., van Tuyll van Serooskerken, A.-M., Haeck, I., & Gemmeke, M. (2024). Betere eczeemzorg dankzij e-learning en informatieboekje: Apothekersassistenten hebben meer zelfvertrouwen bij begeleiden van patiënten. Pharmaceutisch Weekblad, 159(39), 12-13.
Schoenmakers, D. H., van den Berg, S., Timmers, L., Adang, L. A., Bäumer, T., Bosch, A., van de Casteele, M., Datema, M. R., Dekker, H., Donnelly, C., Driessens, M. H. E., Graessner, H., Greger, V., Haddad, T., Höglinger, G. U., van den Hout, H., Jonker, C., Langeveld, M., Lambert, L. J., ... Wolf, N. I. (2024). Framework for Multistakeholder Patient Registries in the Field of Rare Diseases: Focus on Neurogenetic Diseases. Neurology, 103(6), Article e209743. https://doi.org/10.1212/WNL.0000000000209743
Houwen, J., Zwaan, J., Egberts, T., Duyvendak, M., Lalmohamed, A., Fiolet, A., & Mosterd, A. (2024). De invloed van colchicine op de bloedstolling bij patiënten met chronische coronaire aandoeningen die vitamine-K antagonisten gebruiken. Pharmaceutisch Weekblad, 159(38), 23-28. Article e1784. https://www.knmp.nl/resolveuid/20da6d7d876d4d83944f44ff0282626c
Leopold, C., Hagens, A., Dai, J., Tordrup, D., Dolgorsuren, S., Grafton, D., Huikuri, S., Jung, J., Roberts, E., Stanton, R., Tarlton, D., & Webb, D. (2024). Investment Case for Air Pollution Reduction in Mongolia. UNDP. https://www.undp.org/mongolia/publications/investment-case-air-pollution-reduction-mongolia
Santa-Ana-Téllez, Y., & Elseviers, M. (2024). Comparison of drug utilization across countries. In Drug Utilization Research: Methods and Applications: Second Edition (pp. 260-270). Wiley-Blackwell. https://doi.org/10.1002/9781119911685.ch24
Bennie, M., Kurdi, A., & Santa-Ana-Téllez, Y. (2024). Promoting appropriate use of medicines in a healthcare system. In Drug Utilization Research: Methods and Applications: Second Edition (pp. 248-257). Wiley-Blackwell. https://doi.org/10.1002/9781119911685.ch22
Angerer, E., Burke, M., Dirks, S., Bakker, A., Bilinski Torres, A., & Pieters, T. (2024). The Living Library: a process-based tool for open literature review, probing the boundaries of open science. SN Social Sciences, 4(9), Article 167. https://doi.org/10.1007/s43545-024-00964-z
Lin, L., van der Noort, V., Steeghs, N., Ruiter, G., Beijnen, J. H., & Huitema, A. D. R. (2024). A joint model of longitudinal pharmacokinetic and time-to-event data to study exposure-response relationships: a proof-of-concept study with alectinib. Cancer Chemotherapy and Pharmacology, 94(3), 453-459. https://doi.org/10.1007/s00280-024-04698-w
van Nuland, M., Lobbezoo, A.-F. H., van de Garde, E. M. W., Herbrink, M., van Heijl, I., Bognàr, T., Houwen, J. P. A., Dekens, M., Wannet, D., Egberts, T., & van der Linden, P. D. (2024). Assessing accuracy of ChatGPT in response to questions from day to day pharmaceutical care in hospitals. Exploratory Research in Clinical and Social Pharmacy, 15, Article 100464. https://doi.org/10.1016/j.rcsop.2024.100464
Smale, E. M., Verkerk, E. W., Heerdink, E. R., Egberts, T. C. G., van den Bemt, B. J. F., & Bekker, C. L. (2024). Barriers and facilitators to implement the redispensing of unused oral anticancer drugs in clinical care: A hybrid-effectiveness type I study. Exploratory Research in Clinical and Social Pharmacy, 15, Article 100493. https://doi.org/10.1016/j.rcsop.2024.100493
Coppes, T., Hazen, A. C. M., Zwart, D. L. M., Koster, E. S., van Gelder, T., & Bouvy, M. L. (2024). Characteristics and preventability of medication-related admissions for acute kidney injury and dehydration in elderly patients. European Journal of Clinical Pharmacology, 80(9), 1355-1362. https://doi.org/10.1007/s00228-024-03704-7
The CHEERS-AI Steering Group, Elvidge, J., Hawksworth, C., Avşar, T. S., Zemplenyi, A., Chalkidou, A., Petrou, S., Petykó, Z., Srivastava, D., Chandra, G., Delaye, J., Gomes, M., Knies, S., Nousios, P., Siirtola, P., Wang, J., & Dawoud, D. (2024). Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI). Value in Health, 27(9), 1196-1205. https://doi.org/10.1016/j.jval.2024.05.006
Werkman, N. C. C., Driessen, J. H. M., Klungel, O. H., Schaper, N. S., Souverein, P. C., Stehouwer, C. D. A., & Nielen, J. T. H. (2024). Incretin-based therapy and the risk of diabetic foot ulcers and related events. Diabetes, Obesity and Metabolism, 26(9), 3764-3780. https://doi.org/10.1111/dom.15721
Coppes, T., Philbert, D., van Gelder, T., Bouvy, M. L., & Koster, E. S. (2024). Medication management during sick days: No differences between patients with and without impaired renal function. European Journal of Clinical Investigation, 54(9), Article e14231. https://doi.org/10.1111/eci.14231
van Nuland, M., Erdogan, A., Aςar, C., Contrucci, R., Hilbrants, S., Maanach, L., Egberts, T., & van der Linden, P. D. (2024). Performance of ChatGPT on Factual Knowledge Questions Regarding Clinical Pharmacy. Journal of Clinical Pharmacology, 64(9), 1095-1100. https://doi.org/10.1002/jcph.2443
Kempen, T. G. H., Benaissa, Y., Molema, H., Valk, L. E., Hazen, A. C. M., Heringa, M., Kwint, H.-F., Zwart, D. L. M., Sporrong, S. K., Stewart, D., & van Dijk, L. (2024). Pharmacists' current and potential prescribing roles in primary care in the Netherlands: a case study. Journal of Interprofessional Care, 38(5), 787-798. https://doi.org/10.1080/13561820.2024.2374017
Bennie, M., Santa-Ana-Tellez, Y., Galistiani, G. F., Trehony, J., Despres, J., Jouaville, L. S., Poluzzi, E., Morin, L., Schubert, I., MacBride-Stewart, S., Elseviers, M., Nasuti, P., & Taxis, K. (2024). The prevalence of polypharmacy in older Europeans: A multi-national database study of general practitioner prescribing. British Journal of Clinical Pharmacology, 90(9), 2124-2136. https://doi.org/10.1111/bcp.16113
Ferreira Martins, M. L., Heydari, P., Li, W., Martinez-Chavez, A., el Yattouti, M., Lebre, M. C., Beijnen, J. H., & Schinkel, A. H. (2024). The role of drug efflux and uptake transporters in the plasma pharmacokinetics and tissue disposition of morphine and its main metabolites. Toxicology and Applied Pharmacology, 490, 1-14. Article 117040. https://doi.org/10.1016/j.taap.2024.117040
Julian, E., Solà-Morales, O., Garcia, M. J., Brinkhuis, F., Pavlovic, M., Martín-Saborido, C., Doeswijk, R., Giuliani, R., Willemsen, A., Goettsch, W., Wörmann, B., Dafni, U., Bucher, H. C., Pérez-Valderrama, B., Bernardini, R., Gianfrate, F., Uyl-de Groot, C. A., & Ruof, J. (2024). The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access Academy. Journal of market access & health policy, 12(3), 128-143. https://doi.org/10.3390/jmahp12030011
on behalf of the COSEB Consortium, Korte, E. W. H., Pasmooij, A. M. G., Bolling, M. C., Hickey, S., Hussain, S., Kiritsi, D., Kottner, J., Prinsen, C. A. C., Sauvestre, A., Sendin, G., Spuls, P. I., Tarrats, N., Wally, V., Welponer, T., Laimer, M., & Van Den Akker, P. C. (2024). Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa. British Journal of Dermatology, 191(3), 463-465. https://doi.org/10.1093/bjd/ljae200
Arnamo, A. H., Pluim, D., Huitema, A. D. R., Jacobs, B. A. W., Beijnen, J. H., & Nuijen, B. (2024). Prolonged in-use physicochemical and biological stability of nivolumab and pembrolizumab diluted in saline infusion bags and in partially used medication vials. Journal of Oncology Pharmacy Practice. Advance online publication. https://doi.org/10.1177/10781552241279018
Costa, E., Girotti, S., Mathieu, C., Castellani, C., Ross, J. S., Taylor-Cousar, J. L., & Leufkens, H. G. M. (2024). Differential times of submission and approval of CFTR modulators for the treatment of Cystic Fibrosis in the United States and the European Union. Journal of Cystic Fibrosis. Advance online publication. https://doi.org/10.1016/j.jcf.2024.08.002
Postma, D. J., Heijkoop, M. L. A., De Smet, P. A. G. M., Notenboom, K., Leufkens, H. G. M., & Mantel-Teeuwisse, A. K. (2024). Identifying Medicine Shortages With the Twitter Social Network: Retrospective Observational Study. Journal of Medical Internet Research, 26, Article e51317. https://doi.org/10.2196/51317
Bloem, L. T., Van der Elst, M. E., & Klungel, O. H. (2024). Principles of Pharmacovigilance and Drug Regulation. In J. Jose, A. R. Cox, & V. Paudyal (Eds.), Principles and Practice of Pharmacovigilance and Drug Safety (pp. 135-161). Springer. https://doi.org/10.1007/978-3-031-51089-2_6
Lentzas, A., de Gooijer, M. C., Zuidema, S., Meurs, A., Çitirikkaya, C. H., Venekamp, N., Beijnen, J. H., & van Tellingen, O. (2024). ATP-binding cassette transporter inhibitor potency and substrate drug affinity are critical determinants of successful drug delivery enhancement to the brain. Fluids and Barriers of the CNS, 21(1), Article 62. https://doi.org/10.1186/s12987-024-00562-4
Ellerbroek, H., Schellekens, A. F. A., Kalkman, G. A., Visser, D. A., Kramers, C., Dahan, A., van den Heuvel, S. A. S., Bouvy, M. L., & van Dorp, E. L. A. (2024). Opioid prescribing in the Netherlands during the COVID-19 pandemic: a national register-based study. BMJ Open, 14(8), Article e082369. https://doi.org/10.1136/bmjopen-2023-082369
Embaby, A., Huijberts, S. C. F. A., Wang, L., de Oliveira, R. L., Rosing, H., Nuijen, B., Sanders, J., Hofland, I., van Steenis, C., Kluin, R. J. C., Lieftink, C., Smith, C. G., Blank, C. U., van Thienen, J. V., Haanen, J. B. A. G., Steeghs, N., Opdam, F. L., Beijnen, J. H., Huitema, A. D. R., ... Wilgenhof, S. (2024). A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat following BRAF and MEK Inhibitors in BRAFV600-Mutated Melanoma. Clinical Cancer Research, 30(15), 3157-3166. https://doi.org/10.1158/1078-0432.CCR-23-3171
Schouten, W. M., Roseboom, I. C., Lucas, L., Kabalu Tshiongo, J., Muhindo Mavoko, H., Kayentao, K., Rosing, H., Huitema, A. D. R., Beijnen, J. H., & Dorlo, T. P. C. (2024). Development and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method for the quantification of the antimalarial drug pyronaridine in human whole blood. Journal of Pharmaceutical and Biomedical Analysis, 245, Article 116154. https://doi.org/10.1016/j.jpba.2024.116154
Meertens, M., de Vries, N., Rosing, H., Steeghs, N., Beijnen, J. H., & Huitema, A. D. R. (2024). Analytical Validation of a Volumetric Absorptive Microsampling Method for Therapeutic Drug Monitoring of the Oral Targeted Anticancer Agents, Abiraterone, Alectinib, Cabozantinib, Imatinib, Olaparib, and Sunitinib, and Metabolites. Therapeutic Drug Monitoring, 46(4), 494-502. https://doi.org/10.1097/FTD.0000000000001175
Manson, L. E. N., Nijenhuis, M., Soree, B., de Boer-Veger, N. J., Buunk, A. M., Houwink, E. J. F., Risselada, A., Rongen, G. A. P. J. M., van Schaik, R. H. N., Swen, J. J., Touw, D. J., van Westrhenen, R., Deneer, V. H. M., & Guchelaar, H. J. (2024). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs. European Journal of Human Genetics, 32(8), 903-911. https://doi.org/10.1038/s41431-024-01572-4
Callenbach, M. H. E., Schoenmakers, D., Vreman, R. A., Vijgen, S., Timmers, L., Hollak, C. E. M., Mantel-Teeuwisse, A. K., & Goettsch, W. G. (2024). Illustrating the financial consequences of outcome-based payment models from a payers perspective- the case of autologous gene therapy atidarsagene autotemcel (Libmeldy®). Value in Health, 27(8), 1046-1057. https://doi.org/10.1016/j.jval.2024.05.010
Tillemans, M. P. H., Giezen, T. J., Egberts, T. C. G., Hooijberg, J. H., & Kalisvaart, K. J. (2024). Intranasal vitamin B12 administration in elderly patients: A randomized controlled comparison of two dosage regimens. British Journal of Clinical Pharmacology, 90(8), 1975-1983. https://doi.org/10.1111/bcp.16084
Sadreghaemy, M., Gamba, M. A., Bloem, L. T., & Egberts, T. C. G. (2024). Leftover of Amoxicillin Suspension After Use by Children in the Netherlands. Pharmacoepidemiology and Drug Safety, 33(8), Article e5868. https://doi.org/10.1002/pds.5868
Weir, D. L., Bai, Y. Q., Thavorn, K., Guilcher, S., Kanji, S., Mulpuru, S., & Wodchis, W. (2024). Non-adherence to COPD medications and its association with adverse events: A longitudinal population based cohort study of older adults. Annals of Epidemiology, 96, 88-96. https://doi.org/10.1016/j.annepidem.2023.12.003
Eroglu, TE., Coronel, R., & Gislason, GH. (2024). Use of proton pump inhibitors is associated with increased risk of out-of-hospital cardiac arrest in the general population: a nested case-control study. European Heart Journal - Cardiovascular Pharmacotherapy, 10(5), 413-419. https://doi.org/10.1093/ehjcvp/pvae020
Hoek, J. M., Brenninkmeijer, J., de Vries, Y. A., Meijer, R. R., & van Ravenzwaaij, D. (2024). Assessing the credibility of a drug's effects: identification and judgment of uncertainty by the Dutch Medicines Evaluation Board. Frontiers in Medicine, 11, 1-13. Article 1409259. https://doi.org/10.3389/fmed.2024.1409259
Joosse, I. R., van den Ham, H. A., Mantel-Teeuwisse, A. K., Perumal-Pillay, V. A., & Suleman, F. (2024). Access to childhood cancer medicines in South Africa: a health systems analysis of barriers and enablers. Journal of Pharmaceutical Policy and Practice, 17(1), Article 2372033. https://doi.org/10.1080/20523211.2024.2372033
Brinkhuis, F., Julian, E., van den Ham, H., Gianfrate, F., Strammiello, V., Berntgen, M., Pavlovic, M., Mol, P., Wasem, J., Van Dyck, W., Cardone, A., Dierks, C., Schiel, A., Bernardini, R., Solà-Morales, O., Ruof, J., & Goettsch, W. (2024). Navigating the path towards successful implementation of the EU HTA Regulation: key takeaways from the 2023 Spring Convention of the European Access Academy. Health Research Policy and Systems, 22(1), Article 74. https://doi.org/10.1186/s12961-024-01154-2
Pieters, T. (2024). ‘Help ik ben besmet’ De illusie doorgeprikt van een ‘intelligente’ lockdown. Tijdschrift Voor Geschiedenis, 137(2), 205-214. https://doi.org/10.5117/TVG2024.2.009.PIET
Madrid Paredes, J., Versteeg, J.-W., Vreman, R. A., & Bloem, L. T. (2024). Agreement about Availability of Alternative Treatments for Innovative Drugs Assessed by the EMA and HTA Organizations. Clinical Pharmacology and Therapeutics, 116(1), 136-146. https://doi.org/10.1002/cpt.3252
Jacobs, T. G., Okemo, D., Ssebagereka, A., Mwehonge, K., Njuguna, E. M., Burger, D. M., Colbers, A., Suleman, F., Mantel-Teeuwisse, A. K., & Ooms, G. I. (2024). Availability and stock-outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda. HIV Medicine, 25(7), 805-816. https://doi.org/10.1111/hiv.13635
Callenbach, M. H. E., Goettsch, W. G., Mantel-Teeuwisse, A. K., & Trusheim, M. (2024). Creating win-win-win situations with managed entry agreements? Prioritizing gene and cell therapies within the window of opportunity. Drug Discovery Today, 29(7), Article 104048. https://doi.org/10.1016/j.drudis.2024.104048
Hogervorst, M. A., van Hattem, C. C., Sonke, G. S., Mantel-Teeuwisse, A. K., Goettsch, W. G., & Bloem, L. T. (2024). Healthcare decision-making for tumour-agnostic therapies in Europe: lessons learned. Drug Discovery Today, 29(7), Article 104031. https://doi.org/10.1016/j.drudis.2024.104031
Loos, NHC., Bui, V., de Jong, DH., Lebre, MC., Rosing, H., Beijnen, JH., & Schinkel, AH. (2024). Impact of loperamide on the pharmacokinetics and tissue disposition of ritonavir-boosted oral docetaxel therapy: a preclinical assessment. Cancer Chemotherapy and Pharmacology, 94(1), 79-87. https://doi.org/10.1007/s00280-024-04662-8
Davies, L. E. M., Jansen-Groot Koerkamp, E. A. W., Koster, E. S., Dalusong, K.-J., Koch, B., Schellekens, A., Heringa, M., & Bouvy, M. (2024). Patients' perspectives about the role of primary healthcare providers in long-term opioid therapy: a qualitative study in Dutch primary care. British Journal of General Practice, 74(744), e475-e481. https://doi.org/10.3399/BJGP.2023.0547
van Nuland, M., Snoep, J. J. D., Egberts, T., Erdogan, A., Wassink, R., & van der Linden, P. D. (2024). Poor performance of ChatGPT in clinical rule-guided dose interventions in hospitalized patients with renal dysfunction. European Journal of Clinical Pharmacology, 80(8), 1133-1140. https://doi.org/10.1007/s00228-024-03687-5
Eroglu, T. E., Coronel, R., & Souverein, P. C. (2024). Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study. European heart journal. Cardiovascular pharmacotherapy, 10(4), 289-295. https://doi.org/10.1093/ehjcvp/pvae022
Pasmooij, A. M. G., Mol, P. G. M., Bot, J. C., & Leufkens, H. G. M. (2024). The Evolution of Drug Regulatory Sciences in the Netherlands: More than a Country Report. Clinical Pharmacology and Therapeutics, 116(1), 64-71. https://doi.org/10.1002/cpt.3275
Santeon MIBC-studiegroep, Reesink, D. J., van de Garde, E. M. W., van der Nat, P. B., Los, M., Horenblas, S., & van Melick, H. H. E. (2024). Uitkomsten in de dagelijkse praktijk van eerstelijnschemotherapie voor niet-resectabel stadium III en IV urotheelcarcinoom van de blaas. Tijdschrift voor Urologie, 14(4), 74-84. https://doi.org/10.1007/s13629-024-00425-5
van de Voort, T., Moors, E., Hoekman, J., & Bloem, L. T. (2024). Understanding the transformative nature of initiatives challenging the traditional pharmaceutical model in the gene and cell therapy field. Abstract from EASST-4S 2024 Conference, Amsterdam, Netherlands.
Kanning, J. P., Abtahi, S., Schnier, C., Klungel, O. H., Geerlings, M. I., & Ruigrok, Y. M. (2024). Prescribed Drug Use and Aneurysmal Subarachnoid Hemorrhage Incidence: A Drug-Wide Association Study. Neurology, 102(12), Article e209479. https://doi.org/10.1212/WNL.0000000000209479
Grupstra, R. J., Siiskonen, S. J., & Gardarsdottir, H. (2024). Risicominimalisatiemaatregelen voor geneesmiddelen. Nederlands Tijdschrift voor Geneeskunde, 168.
Maksimova, M. V., van Thiel, G. J. M. W., Tromp, Y., Lechner, R., van Delden, J. J. M., & Bloem, L. T. (2024). Balancing ethical norms and duties for the introduction of new medicines through conditional marketing authorization: a research agenda. Frontiers in Medicine, 11, Article 1408553. https://doi.org/10.3389/fmed.2024.1408553
van den Broek, W. W. A., Gimbel, M. E., Hermanides, R. S., Runnett, C., Storey, R. F., Knaapen, P., Emans, M. E., Oemrawsingh, R. M., Cooke, J., Galasko, G., Walhout, R., Stoel, M. G., von Birgelen, C., van Bergen, P. F. M. M., Brinckman, S. L., Aksoy, I., Liem, A., van't Hof, A. W. J., Jukema, J. W., ... ten Berg, J. M. (2024). The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndrome. International Journal of Cardiology, 405, Article 131940. https://doi.org/10.1016/j.ijcard.2024.131940
De Graef, M., Serraes, B., Van Rompay, V., Dijkstra, N. E., Heerdink, E. R., & Dilles, T. (2024). Implementation of Pharmaceutical Technical Assistants on Hospital Wards and Their Impact on Patient Safety and Quality of Care: A Qualitative Study on Nurses' Experiences and Perceptions. Journal of Nursing Management, 2024, Article 7894331. https://doi.org/10.1155/2024/7894331
Schoegje, T., Hardman, L., Vries, A. D., & Pieters, T. (2024). Reconstructing the decision-making processes of a city council based on references between documents. In H.-C. Liao, D. D. Cid, M. A. Macadar, & F. Bernardini (Eds.), dg.o '24: Proceedings of the 25th Annual International Conference on Digital Government Research (pp. 525-533). (ACM International Conference Proceeding Series). Association for Computing Machinery. https://doi.org/10.1145/3657054.3657116
Joosse, I. R., van den Ham, H. A., Mantel-Teeuwisse, A. K., & Suleman, F. (2024). A proposed analytical framework for qualitative evaluation of access to medicines from a health systems perspective. BMC Research Notes, 17(1), Article 159. https://doi.org/10.1186/s13104-024-06764-1
de Koning, G. H. P., Egberts, TCG., & Zijl, T. (2024). Het echte probleem is niet terugmelden. Pharmaceutisch Weekblad, 159(23), 20-21. https://www.pw.nl/achtergrond/2024/het-echte-probleem-is-2018niet-terugmelden2019
Graafsma, J., Murphy, R. M., Van De Garde, E. M. W., Karapinar-Çarkit, F., Derijks, H. J., Hoge, R. H. L., Klopotowska, J. E., & Van Den Bemt, P. M. L. A. (2024). The use of artificial intelligence to optimize medication alerts generated by clinical decision support systems: a scoping review. Journal of the American Medical Informatics Association, 31(6), 1411-1422. https://doi.org/10.1093/jamia/ocae076
Rijmers, J., Retmana, I. A., Bui, V., Arguedas, D., Lebre, M. C., Sparidans, R. W., Beijnen, J. H., & Schinkel, A. H. (2024). ABCB1 attenuates brain exposure to the KRASG12C inhibitor opnurasib whereas binding to mouse carboxylesterase 1c influences its plasma exposure. Biomedicine and Pharmacotherapy, 175, Article 116720. https://doi.org/10.1016/j.biopha.2024.116720
Annema, P. A., Derijks, H. J., Bouvy, M. L., & van Marum, R. J. (2024). Impact of Drug Recalls on Patients in The Netherlands: A 5-Year Retrospective Data Analysis. Clinical Pharmacology and Therapeutics, 115(6), 1365-1371. https://doi.org/10.1002/cpt.3220
Shea, B., Pardo, J. P., Grosskleg, S., Beaton, D. E., Conaghan, P., Goettsch, W., Hofstetter, C., Maxwell, L., Musaus, J., Ollendorf, D., Schultz, G., Stevens, R., Strand, V., Tugwell, P., Williamson, P., Tunis, S., & Simon, L. S. (2024). Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023. Seminars in Arthritis and Rheumatism, 66, Article 152438. https://doi.org/10.1016/j.semarthrit.2024.152438
Li, W., Sparidans, R. W., Wang, Y., Martins, M. L. F., de Waart, D. R., van Tellingen, O., Song, J.-Y., Lebre, M. C., van Hoppe, S., Wagenaar, E., Beijnen, J. H., & Schinkel, A. H. (2024). Interplay of OATP1A/1B/2B1 uptake transporters and ABCB1 and ABCG2 efflux transporters in the handling of bilirubin and drugs. Biomedicine and Pharmacotherapy, 175, Article 116644. https://doi.org/10.1016/j.biopha.2024.116644
Kempen, T. G. H., van Dijk, L., Floor-Schreudering, A., Kohli, A., Kwint, H. F., Schackmann, L., van Tuyl, L. H. D., & Heringa, M. (2024). Potential for pharmacist prescribing in primary care: A Dutch citizen perspective. Exploratory Research in Clinical and Social Pharmacy, 14, Article 100453. https://doi.org/10.1016/j.rcsop.2024.100453
Jansen, M. S., Dekkers, O. M., le Cessie, S., Hooft, L., Gardarsdottir, H., de Boer, A., & Groenwold, R. H. H. (2024). Real-World Evidence to Inform Regulatory Decision Making: A Scoping Review. Clinical Pharmacology and Therapeutics, 115(6), 1269-1276. https://doi.org/10.1002/cpt.3218
van Gelder, T. G., van Diem-Zaal, I. J., Dijkstra-Kersten, S. M. A., de Mul, N., Lalmohamed, A., & Slooter, A. J. C. (2024). The risk of delirium after sedation with propofol or midazolam in intensive care unit patients. British Journal of Clinical Pharmacology, 90(6), 1471-1479. https://doi.org/10.1111/bcp.16031
Lin, L., Houwink, A. P. I., van Dieren, J. M., Wolthuis, E. K., van Thienen, J. V., van der Heijden, M. S., Haanen, J. B. A. G., Beijnen, J. H., & Huitema, A. D. R. (2024). Treatment patterns and survival outcomes of patients admitted to the intensive care unit due to immune-related adverse events of immune checkpoint inhibitors. Cancer Medicine, 13(12), 1-7. Article e7302. https://doi.org/10.1002/cam4.7302
Spin, E. L., Mantel-Teeuwisse, A. K., & Pasmooij, A. M. G. (2024). International regulatory and publicly-funded initiatives to advance drug repurposing. Frontiers in Medicine, 11, Article 1387517. https://doi.org/10.3389/fmed.2024.1387517
Costa, E., Isgrò, A., de Montalembert, M., Leufkens, H. G. M., Ware, R. E., & De Franceschi, L. (2024). Successes and pitfalls in orphan drug development for sickle cell disease. Blood advances, 8(10), 2455-2465. https://doi.org/10.1182/bloodadvances.2023011730
Joosse, I. R. (2024). Forging new paths in access to medicines research: Towards equitable access for all. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2303
Meijvis, V. A. M. (2024). The CombiConsultation: Patient-centred pharmaceutical care by interprofessional collaboration. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2200
Arnoldy, L., Gauci, S., Lassemillante, A.-C. M., Verster, J. C., Macpherson, H., Minihane, A.-M., Scholey, A., Pipingas, A., & White, D. J. (2024). Towards Consistency in Dietary Pattern Scoring: Standardising Scoring Workflows for Mediterranean, DASH, and MIND Diets Using 24-Hour Recall and Two Variations of a Food Frequency Questionnaire. British Journal of Nutrition, 131(9), 1554-1577. https://doi.org/10.1017/S0007114524000072
Chandra, G., Wang, JF., Siirtola, P., & Röning, J. (2024). Leveraging machine learning for predicting acute graft-versus-host disease grades in allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukaemia. BMC Medical Research Methodology, 24(1), Article 112. https://doi.org/10.1186/s12874-024-02237-y
Ooms, G. I., Usman, M. A., Reed, T., van den Ham, H. A., & Mantel-Teeuwisse, A. K. (2024). The impact of scheduling ketamine as an internationally controlled substance on anaesthesia care in Sub-Saharan Africa: a case study and key informant interviews. BMC Health Services Research, 24(1), Article 598. https://doi.org/10.1186/s12913-024-11040-w
Gini, R., Pajouheshnia, R., Gardarsdottir, H., Bennett, D., Li, L., Gulea, C., Wientzek-Fleischmann, A., Bazelier, M. T., Burcu, M., Dodd, C., Durán, C. E., Kaplan, S., Lanes, S., Marinier, K., Roberto, G., Soman, K., Zhou, X., Platt, R., Setoguchi, S., & Hall, G. C. (2024). Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review. Pharmacoepidemiology and Drug Safety, 33(5), Article e5787. https://doi.org/10.1002/pds.5787
Schultze, A., Martin, I., Messina, D., Bots, S., Belitser, S., José Carreras-Martínez, J., Correcher-Martinez, E., Urchueguía-Fornes, A., Martín-Pérez, M., García-Poza, P., Villalobos, F., Pallejà-Millán, M., Alberto Bissacco, C., Segundo, E., Souverein, P., Riefolo, F., Durán, C. E., Gini, R., Sturkenboom, M., ... Douglas, I. (2024). A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases. Vaccine, 42(12), 3039-3048. https://doi.org/10.1016/j.vaccine.2024.03.043